Variant report
Variant | nsv970647 |
---|---|
Chromosome Location | chr6:48679446-48684158 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:48677900..48680062-chr6:48689263..48690810,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs552432625 | chr6:48681415-48681416 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs541499528 | chr6:48681422-48681423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs560089441 | chr6:48681441-48681442 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs565727446 | chr6:48681444-48681445 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs145522000 | chr6:48681463-48681464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs571530658 | chr6:48681492-48681493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs532525125 | chr6:48681506-48681507 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs189438199 | chr6:48681534-48681535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs550873740 | chr6:48681553-48681554 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs569492583 | chr6:48681627-48681628 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs536950038 | chr6:48681658-48681659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs548321518 | chr6:48681696-48681697 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs180863839 | chr6:48681766-48681767 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs534304660 | chr6:48681772-48681773 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs559065368 | chr6:48681777-48681778 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs73486407 | chr6:48681791-48681792 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs537996302 | chr6:48681809-48681810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs534910679 | chr6:48681843-48681844 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs563719307 | chr6:48681845-48681846 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs556313010 | chr6:48681859-48681860 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs574687897 | chr6:48681888-48681889 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs184746364 | chr6:48681920-48681921 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs548760007 | chr6:48681931-48681932 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs2495919 | chr6:48681963-48681964 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs571671287 | chr6:48682010-48682011 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs534837061 | chr6:48682019-48682020 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs147722822 | chr6:48682042-48682043 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs113611580 | chr6:48682181-48682182 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs189516348 | chr6:48682209-48682210 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs73486408 | chr6:48682225-48682226 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs530360901 | chr6:48682258-48682259 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs548830154 | chr6:48682271-48682272 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs566773511 | chr6:48682286-48682287 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs116694636 | chr6:48682358-48682359 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs181504088 | chr6:48682465-48682466 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs570997833 | chr6:48682494-48682495 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs538336583 | chr6:48682523-48682524 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs186044900 | chr6:48682530-48682531 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs574556983 | chr6:48682568-48682569 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs535398575 | chr6:48682577-48682578 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs557668944 | chr6:48682657-48682658 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs553990153 | chr6:48682689-48682690 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs9463437 | chr6:48682769-48682770 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs545436285 | chr6:48682775-48682776 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs563738299 | chr6:48682833-48682834 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs575761367 | chr6:48682857-48682858 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs566114256 | chr6:48682861-48682862 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs191759447 | chr6:48682907-48682908 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs562958189 | chr6:48682909-48682910 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs181364005 | chr6:48682921-48682922 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gastric cancer | 17908304 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Osteosarcoma | 21197465 | CNVD |
Gastric cancer | 24379144 | CNVD |
Neuroblastoma | 18923191 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 21364760 | CNVD |
Follicular lymphoma | 16790693 | CNVD |
Osteosarcoma | 19286668 | CNVD |
Neurocytoma | 17123091 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Heart disease | 21282601 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Breast cancer | 16608533 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Neuroblastoma | 19686582 | CNVD |
Neuroblastoma | 17289879 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Bladder cancer | 21909424 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:48681400-48682200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr6:48681400-48682400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr6:48681400-48682600 | Enhancers | Pancreatic Islets | Pancreatic Islet |
4 | chr6:48681400-48682800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
5 | chr6:48681800-48682200 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
6 | chr6:48681800-48682800 | Enhancers | Brain Germinal Matrix | brain |
7 | chr6:48682200-48683400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr6:48683600-48683800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |